Patents/Assignees

Avalo Therapeutics, Inc.

2 patents in portfolio

US12331107utility2025
Methods of Treating Pneumonia or Respiratory Failure Associated with COVID-19 by Administering an Anti-light Antibody
0 cites
US11708406utility2023
Method of Treating Acute Respiratory Distress Syndrome (ARDS) or Acute Lung Injury (ALI) Associate with COVID-19 by Administering an Anti-light Antibody
0 cites